0.868

3.27% -0.0293

After Hours: .87 0.002 +0.23%

Standard Biotools Inc (LAB)

Overview News Price History Option Chain Financials Discussions Forecast

Standard Biotools Inc stock is traded at $0.868, with a volume of 1.26M. It is down -3.27% in the last 24 hours and up +5.51% over the past month. Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

Previous Close:

$0.8973

Open:

$0.8846

24h Volume:

1.26M

Relative Volume:

0.37

Market Cap:

$339.79M

Revenue:

$86.26M

Net Income/Loss:

$-50.08M

P/E Ratio:

-3.5443

EPS:

-0.2449

Net Cash Flow:

$-94.48M

1W Performance:

+4.18%

1M Performance:

+5.51%

6M Performance:

-38.00%

1Y Performance:

-34.74%

1-Day Range:

$0.855

$0.9004

1-Week Range:

$0.766

$0.9165

52-Week Range:

$0.7029

$1.72

Standard Biotools Inc Stock (LAB) Company Profile

Name

Standard Biotools Inc

Sector

Healthcare (1079)

Industry

Medical Devices (140)

Phone

(650) 266-6000

Address

50 MILK STREET, BOSTON

Employee

389

Twitter

Next Earnings Date

2026-08-05

Latest SEC Filings

LAB's Discussions on Twitter

Compare LAB vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LAB Standard Biotools Inc	0.868	303.23M	86.26M	-50.08M	-94.48M	-0.2449
ABT Abbott Laboratories	105.74	182.00B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	325.74	129.09B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	85.40	107.81B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	46.73	67.64B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.03	47.81B	6.30B	1.07B	1.09B	1.8406

Standard Biotools Inc Stock (LAB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-13-25	Downgrade	TD Cowen	Buy → Hold
Feb-27-25	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Apr-16-24	Initiated	TD Cowen	Buy
Apr-04-24	Initiated	Jefferies	Buy
Jul-12-23	Initiated	KeyBanc Capital Markets	Overweight

Standard Biotools Inc Stock (LAB) Latest News

Jul 28, 2026

Standard BioTools Sells Mass Cytometry Business Amid Pending Merger With Treeline Biosciences - Moomoo

Jul 28, 2026

- SEC.gov

Jul 28, 2026

Standard BioTools (LAB) plans sale of Mass Cytometry business alongside Treeline deal - Stock Titan

Jul 28, 2026

Standard BioTools sells mass cytometry unit, gets $30M buyout - Investing.com

Jul 28, 2026

Standard BioTools (NASDAQ: LAB) nets $30M Illumina buyout, sells mass cytometry arm - Stock Titan

Jul 28, 2026

Standard BiotoolsEnters Termination, Waiver And Release Agreement With Illumina On July 24, 2026SEC Filing - TradingView

Jul 28, 2026

Standard BioTools Sells Mass Cytometry Unit for $5 Million Note and Nets $30 Million From Illumina - TradingView

Jul 28, 2026

Standard BioTools Announces Sale of Mass Cytometry Business - GlobeNewswire

Jul 28, 2026